V. Marsh

Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors.

J. Blake, E. Laird, M. Drew, 2007, Bioorganic & medicinal chemistry letters.

Potent and selective mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors. 1. 4-(4-bromo-2-fluorophenylamino)-1- methylpyridin-2(1H)-ones.

J. Lyssikatos, K. Koch, R. Woessner, 2006, Journal of medicinal chemistry.

Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach.

J. S. Johnson, H. Wild, D. Rogers, 2001, Bioorganic & medicinal chemistry letters.

Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor

Vivienne Marsh, S. Gross, B. Brandhuber, 2007, Clinical Cancer Research.

Abstract 2515: Preclinical Development of ARRY-162, A Potent and Selective MEK 1/2 Inhibitor

S. Gross, J. Lyssikatos, K. Koch, 2010 .

Preclinical development of ARRY-142886, a potent and selective MEK inhibitor

S. Gross, B. Brandhuber, T. Morales, 2004 .

Stereoconfiguration markedly affects the biochemical and biological properties of phosphorothioate analogs of 2-5A core, (A2'p5')2A.

Brian, B. Schryver, D. A. Eppstein, 1986, The Journal of biological chemistry.